BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12200455)

  • 1. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
    Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
    Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
    Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
    Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
    Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
    Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
    Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats.
    Jeyabalan A; Kerchner LJ; Fisher MC; McGuane JT; Doty KD; Conrad KP
    J Appl Physiol (1985); 2006 Jun; 100(6):1955-63. PubMed ID: 16484357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
    Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.
    Lenhart JA; Ryan PL; Ohleth KM; Palmer SS; Bagnell CA
    Endocrinology; 2002 Jan; 143(1):91-8. PubMed ID: 11751597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
    Kondapaka SB; Fridman R; Reddy KB
    Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
    Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
    J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.
    Paquette B; Baptiste C; Therriault H; Arguin G; Plouffe B; Lemay R
    Br J Cancer; 2007 Dec; 97(11):1505-12. PubMed ID: 17987037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
    Li H; Simon H; Bocan TM; Peterson JT
    Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
    Leśniak-Walentyn A; Hrabia A
    Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
    Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
    Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.